Guest Editorial California Institute of Regenerative Medicine and Cancer Research: A promise broken? February 20, 2026Vol.52 No.07By Stephen J. Forman
Sponsored Rewriting immune regulation with the CD6/CTLA‑4 CAR‑Treg platform February 20, 2026Vol.52 No.07By Christine Brown and Enrique Montero
Cancer Policy At Friends meeting, Pazdur, Woodcock lament FDA’s failure to protect the agency staff from political interference, warn of “lasting implications” February 20, 2026Vol.52 No.07By Jacquelyn Cobb and Claire Marie Porter
Cancer Policy Bayer agrees to $7.25B settlement over lawsuits alleging Roundup weedkiller caused cancer February 20, 2026Vol.52 No.07By Sara Willa Ernst
In Brief James Downing to step down as president and CEO of St. Jude to focus on global pediatric medicine February 20, 2026Vol.52 No.07
In Brief Alice Soragni joins CU Anschutz to launch functional personalized medicine initiative February 20, 2026Vol.52 No.07
In Brief WVU Cancer Institute first in the world to treat ultra-rare leukemia using novel subcutaneous immunotherapy February 20, 2026Vol.52 No.07
In Brief University of Illinois Cancer Center creates collaborative Oncogeneralist Training Program February 20, 2026Vol.52 No.07
In Brief CPRIT approves more than $15M in new funding for cancer research and recruitment February 20, 2026Vol.52 No.07
